St George's, University of London

Funded awards at St George's, University of London.

Funded awards
275
Published Funding
£87.5M
Average published award
£403K
Active funded awards
32

Amounts are published for 217 of 275 funded awards. Data as of 16 July 2026.

See funded awards Open the Map

The biggest topic here is Heart, Stroke & Blood — 59 grants (21%). The busiest year was 2007, with 20 grants.

Funded Awards by Year

View data table
YearFunded awards
200616
200720
200814
200915
201015
201120
201214
201314
201413
201519
201611
201716
201811
201912
202016
202110
20227
202311
202415
20256

Grants

Fluconazole plus flucytosine vs fluconazole alone for cryptococcal antigen-positive patients identified through screening: A randomised trialSt George's, University of LondonMRC£5.1M2021Active
Enabling and translating advances in diagnostic and communication technologies to reduce the burden of STIsSt George's, University of LondonMRC£3.9M2011Completed
A phase III randomised controlled trial of oral fluconazole plus flucytosine versus amphotericin B-based therapy for oSt George's, University of LondonMRC£3.2M2012Completed
MICA: Clinical development of erythrocyte encapsulated thymidine phosphorylase - a therapy for mitochondrial neurogastrointestinal encephalomyopathySt George's, University of LondonMRC£3.2M2014Completed
A randomized trial to evaluate the toxicity and efficacy of 1200mg and 1800mg rifampicin daily for 4 months in the treatment of pulmonary tuberculosisSt George's, University of LondonMRC£3.0M2016Completed
Integrating deep phenotyping and functional genomics to understand the mechanistic basis of primary lymphatic anomaliesSt George's, University of LondonMRC£2.8M2024Active
The Genomic basis of Unexplained Cardiac Arrest: The GenUCA Investigators (joint funding with DZHK and DHF)St George's, University of LondonBHF£772K2021Completed
Pregnancy and Infant PrEparedness pLatform IN EuropeSt George's, University of LondonEC£747K2025Active
Antimicrobial Resistance Gene Transfer in MRSA: Novel Mechanisms, Barriers, and Environmental controlsSt George's, University of LondonMRC£613K2025Completed
Moving maternal Group B Streptococcal vaccines into clinical effectiveness trials.St George's, University of LondonUKRI£572K2023Completed
Posttranslational regulation of tumour suppressor p16 (CDKN2A) in human cell senescence and cancerSt George's, University of LondonMRC£492K2025Active
Candi-NET: Integrating Candidaemia trial samples, Data and Infrastructure to define Novel clinical trial Endpoints and Treatment strategiesSt George's, University of LondonMRC£363K2025Active
PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa (PROTECT)St George's, University of LondonUKRI£350K2024Active
Integrating deep phenotyping and functional genomics to understand the mechanistic basis of primary lymphatic anomalies (Joint funding with MRC)St George's, University of LondonBHF£350K2024Active
The rare arrhythmia syndrome evaluation (RASE) 100K genomes project: enhanced phenotyping for greater insightsSt George's, University of LondonBHF£350K2024Active
The role of the TIGIT immune checkpoint axis in susceptibility to infection in decompensated cirrhosisSt George's, University of LondonMRC£317K2023Completed
Magnetic Resonance Imaging of Primary Lymphoedema: a Tool for Diagnosis and Evaluating TreatmentSt George's, University of LondonBHF£292K2025Active
Causes and MEchanisms foR non-atopic Asthma in childrenSt George's, University of LondonEC£279K2021Active
Protein biomarkers: Improving risk stratification in arrhythmogenic cardiomyopathySt George's, University of LondonBHF£269K2023Active
Exploring the role of neuromuscular excitability in sudden infant deathSt George's, University of LondonMRC£263K2021Completed

Page 1 of 3